Functional cell models of the gut and their applications in food microbiology — A review

Abstract Animal experimentation has a long tradition for risk assessment of new drugs before they reach the clinic. To reduce expensive animal experimentation, attempts have been made to build inexpensive and convenient intestinal functional cell models to study toxicity and bioavailability of new substances along with providing relevant models to study interactions between the host, pathogens and intestinal microflora. We review the available cell lines and models of the intestine and their potential uses. Tumor derived cell lines such as Caco-2, T84 and HT-29 are widely used despite many drawbacks, which are discussed with respect to complexity of the gut, where various cell types interact with commensal microbiota and gut-associated lymphoid tissue. To address this complexity, 3D models of human and animal gut represent a promising in vitro system to mimic in vivo situation without the use of transformed cell lines.

[1]  H Cheng,et al.  Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. IV. Paneth cells. , 1974, The American journal of anatomy.

[2]  B. Weintraub,et al.  A distinctive form of human chorionic gonadotropin beta-subunit-like material produced by cervical carcinoma cells. , 1986, Cancer research.

[3]  K. Michaelsen,et al.  Screening of Probiotic Activities of Forty-Seven Strains of Lactobacillus spp. by In Vitro Techniques and Evaluation of the Colonization Ability of Five Selected Strains in Humans , 1999, Applied and Environmental Microbiology.

[4]  A. Pshezhetsky,et al.  Gene expression profiles of normal proliferating and differentiating human intestinal epithelial cells: A comparison with the Caco‐2 cell model , 2006, Journal of cellular biochemistry.

[5]  B. Biavati,et al.  Gut health promoting activity of new putative probiotic/protective Lactobacillus spp. strains: a functional study in the small intestinal cell model. , 2009, International journal of food microbiology.

[6]  J. Sanderson,et al.  The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea. , 2009, The Lancet. Infectious diseases.

[7]  B. Marian In vitro models for the identification and characterization of tumor-promoting and protective factors for colon carcinogenesis. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[8]  S. Cutting,et al.  The Safety of Two Bacillus Probiotic Strains for Human Use , 2008, Digestive Diseases and Sciences.

[9]  K. Mountzouris,et al.  Effects of a multi-species probiotic on biomarkers of competitive exclusion efficacy in broilers challenged with Salmonella enteritidis , 2009, British poultry science.

[10]  Nicki Panoskaltsis,et al.  Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. , 2006, The New England journal of medicine.

[11]  T. Chen,et al.  WiDr is a derivative of another colon adenocarcinoma cell line, HT-29. , 1987, Cancer genetics and cytogenetics.

[12]  M. Jakobsen,et al.  Interactions of macrophages with probiotic bacteria lead to increased antiviral response against vesicular stomatitis virus. , 2007, Antiviral research.

[13]  L. Biancone,et al.  Resident bacterial flora and immune system. , 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[14]  Qian Yang,et al.  Diversity of tight junctions (TJs) between gastrointestinal epithelial cells and their function in maintaining the mucosal barrier , 2009, Cell biology international.

[15]  W. Walker,et al.  Inflammation in the developing human intestine: A possible pathophysiologic contribution to necrotizing enterocolitis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Tadao Saito,et al.  Toll-like receptor 4 and cytokine expression involved in functional immune response in an originally established porcine intestinal epitheliocyte cell line. , 2008, Biochimica et biophysica acta.

[17]  A. Corfield,et al.  Management of the human mucosal defensive barrier: evidence for glycan legislation , 2009, Biological chemistry.

[18]  Dennis Brown,et al.  Hydrocortisone modulates cholera toxin endocytosis by regulating immature enterocyte plasma membrane phospholipids. , 2008, Gastroenterology.

[19]  M. Jakobsen,et al.  Nitric oxide (NO) production in mammalian non-tumorigenic epithelial cells of the small intestine and macrophages induced by individual strains of lactobacilli and bifidobacteria , 2009 .

[20]  Ho-Chul Shin,et al.  Why is it Challenging to Predict Intestinal Drug Absorption and Oral Bioavailability in Human Using Rat Model , 2006, Pharmaceutical Research.

[21]  J. Nicoli,et al.  Probiotics and mucosal barrier in children , 2008, Current opinion in clinical nutrition and metabolic care.

[22]  S. Hakomori Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. , 1996, Cancer research.

[23]  K. Isselbacher,et al.  Cytotoxic effects and metabolism of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in duodenal and ileal epithelial cell cultures. , 1981, Journal of the National Cancer Institute.

[24]  J. E. Shannon,et al.  Examination of ATCC stocks for HeLa marker chromosomes in human cell lines , 1976, Nature.

[25]  F. Lefèvre,et al.  Establishment of a functional cell culture model of the pig small intestine, LINZ, ALTEX 23 , 2006 .

[26]  B. McCormick The use of transepithelial models to examine host-pathogen interactions. , 2003, Current opinion in microbiology.

[27]  Avrelija Cencic,et al.  Application of Measurements of Transepithelial Electrical Resistance of Intestinal Epithelial Cell Monolayers To Evaluate Probiotic Activity , 2005, Applied and Environmental Microbiology.

[28]  C. Grangette,et al.  Differential crosstalk between epithelial cells, dendritic cells and bacteria in a co-culture model. , 2009, International journal of food microbiology.

[29]  J. Alper Turning Sweet on Cancer , 2003, Science.

[30]  Francisco Guarner,et al.  Enteric Flora in Health and Disease , 2006, Digestion.

[31]  C. Field,et al.  Ganglioside composition of differentiated Caco-2 cells resembles human colostrum and neonatal rat intestine. , 2008, The British journal of nutrition.

[32]  G. Bai,et al.  NMR metabolomic analysis of caco-2 cell differentiation. , 2009, Journal of proteome research.

[33]  A. Panja A Novel Method for the Establishment of a Pure Population of Nontransformed Human Intestinal Primary Epithelial Cell (HIPEC) Lines in Long Term Culture , 2000, Laboratory Investigation.

[34]  R A Morrison,et al.  Current methodologies used for evaluation of intestinal permeability and absorption. , 2000, Journal of pharmacological and toxicological methods.

[35]  M. Pollmann,et al.  Characterization of a porcine intestinal epithelial cell line for in vitro studies of microbial pathogenesis in swine , 2006, Histochemistry and Cell Biology.

[36]  J. Orenstein,et al.  Characterization of Encephalitozoon (Septata) intestinalis Isolates Cultured from Nasal Mucosa and Bronchoalveolar Lavage Fluids of Two AIDS Patients , 1996, Journal of Eukaryotic Microbiology.

[37]  S. Salminen,et al.  Protection mechanism of probiotic combination against human pathogens: in vitro adhesion to human intestinal mucus. , 2006, Asia Pacific journal of clinical nutrition.

[38]  Y. Benno,et al.  Recent advances in molecular approaches to gut microbiota in inflammatory bowel disease. , 2009, Current pharmaceutical design.

[39]  Felice-Alessio Bava,et al.  Human colon fibroblasts induce differentiation and proliferation of intestinal epithelial cells through the direct paracrine action of keratinocyte growth factor , 2009, Journal of cellular physiology.

[40]  F. Shanahan,et al.  Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials , 1999, Antonie van Leeuwenhoek.

[41]  Y. Miyamoto,et al.  A modified fast (4 day) 96-well plate Caco-2 permeability assay. , 2009, Journal of pharmacological and toxicological methods.

[42]  B. Finlay,et al.  Enteropathogenic Escherichia coli decreases the transepithelial electrical resistance of polarized epithelial monolayers , 1993, Infection and immunity.

[43]  G. Galbraith Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412Suntharalingam G, Perry MR, Ward S, et al (Northwick Park and St Mark's Hosp, London; Hammersmith Hosp, London; Imperial College, London) N Engl J Med 355:1018–1028, 2006§ , 2007 .

[44]  L. Ellis,et al.  Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. , 1996, Journal of the National Cancer Institute.

[45]  M. Gareau,et al.  Strain-specific probiotic (Lactobacillus helveticus) inhibition of Campylobacter jejuni invasion of human intestinal epithelial cells. , 2009, FEMS microbiology letters.

[46]  M. Omary,et al.  Identification of cytokeratins as accessory mediators of Salmonella entry into eukaryotic cells. , 2002, Life sciences.

[47]  P. Berthon,et al.  Establishment and characterisation of ovine blood monocyte-derived cell lines. , 2001, Veterinary immunology and immunopathology.

[48]  J. Beaulieu,et al.  Tenascin in the developing and adult human intestine. , 2000, Histology and histopathology.

[49]  R. Clancy Immunobiotics and the probiotic evolution. , 2003, FEMS immunology and medical microbiology.

[50]  H. Weingartl,et al.  A novel eukaryotic cell culture model to study antiviral activity of potential probiotic bacteria. , 2007, International journal of food microbiology.

[51]  M. Niku,et al.  Identification of major cell types in paraffin sections of bovine tissues , 2006, BMC veterinary research.

[52]  J. Beaulieu Extracellular matrix components and integrins in relationship to human intestinal epithelial cell differentiation. , 1997, Progress in histochemistry and cytochemistry.

[53]  R H Whitehead,et al.  Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[54]  S. Cutting,et al.  The use of bacterial spore formers as probiotics. , 2005, FEMS microbiology reviews.

[55]  G. Gibson,et al.  Prebiotics and resistance to gastrointestinal infections , 2005, British Journal of Nutrition.

[56]  Yan Jiang,et al.  The effect of differentiation on 1,25 dihydroxyvitamin D‐mediated gene expression in the enterocyte‐like cell line, Caco‐2 , 2009, Journal of cellular physiology.

[57]  M. Braun,et al.  Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines , 1987, Journal of virology.

[58]  J. Kraehenbuhl,et al.  Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. , 1997, Science.

[59]  X. J. Li,et al.  The adhesion of putative probiotic lactobacilli to cultured epithelial cells and porcine intestinal mucus , 2008, Journal of applied microbiology.

[60]  R. Dwek,et al.  Altered glycosylation of proteins in cancer: what is the potential for new anti-tumour strategies. , 2008, Anti-cancer agents in medicinal chemistry.

[61]  J. Beaulieu Integrins and human intestinal cell functions. , 1999, Frontiers in bioscience : a journal and virtual library.

[62]  Meenu Sharma,et al.  Induction and inhibition of CD40-CD40 ligand interactions: a new strategy underlying host-virus relationships. , 1998, Journal of immunology.

[63]  C. P. Leblond,et al.  Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. , 1974, The American journal of anatomy.

[64]  W. Walker,et al.  ADP-ribosylation factors regulate the development of CT signaling in immature human enterocytes. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[65]  R. Korpela,et al.  Effects of Multispecies Probiotic Combination on Helicobacter pylori Infection In Vitro , 2008, Clinical and Vaccine Immunology.

[66]  M. Falagas,et al.  Bacterial interference for the prevention and treatment of infections. , 2008, International journal of antimicrobial agents.

[67]  B. Margolis,et al.  Tight junctions and cell polarity. , 2006, Annual review of cell and developmental biology.

[68]  K. Isselbacher,et al.  Fibronectin synthesis by epithelial crypt cells of rat small intestine. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[69]  A. Quaroni,et al.  Cell dynamics and differentiation of conditionally immortalized human intestinal epithelial cells. , 1997, Gastroenterology.

[70]  S. Normark,et al.  Characterization of microbial host receptors. , 1994, Methods in enzymology.

[71]  E. Wimmer,et al.  Immunofluorescence analysis of poliovirus receptor expression in Peyer's patches of humans, primates, and CD155 transgenic mice: implications for poliovirus infection. , 2002, The Journal of infectious diseases.

[72]  J. Beaulieu,et al.  Human cell models to study small intestinal functions: Recapitulation of the crypt‐villus axis , 2000, Microscopy research and technique.

[73]  G. Henle,et al.  The establishment of strains of human cells in tissue culture. , 1957, Journal of immunology.

[74]  Y. Benno,et al.  Adhesion of Bifidobacterium Spp. to Human Intestinal Mucus , 2001, Microbiology and immunology.

[75]  L. Smith,et al.  Altered morphology in cultured rat intestinal epithelial IEC-6 cells is associated with alkaline phosphatase expression. , 2003, Tissue & cell.

[76]  D. Singh,et al.  The microbes of the intestine: an introduction to their metabolic and signaling capabilities. , 2008, Endocrinology and metabolism clinics of North America.

[77]  C. Hill,et al.  Understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens. , 2009, Advances in food and nutrition research.

[78]  D. Corbeil,et al.  Polarized distribution of neutral endopeptidase 24.11 at the cell surface of cultured human intestinal epithelial Caco-2 cells. , 1992, The Biochemical journal.

[79]  C. Edwards,et al.  Intestinal flora during the first months of life: new perspectives , 2002, British Journal of Nutrition.

[80]  S. Salminen,et al.  Adhesion of selected Bifidobacterium strains to human intestinal mucus and the role of adhesion in enteropathogen exclusion. , 2005, Journal of food protection.

[81]  J. Beaulieu,et al.  Integrin α8β1 regulates adhesion, migration and proliferation of human intestinal crypt cells via a predominant RhoA/ROCK-dependent mechanism , 2009, Biology of the cell.

[82]  R. Pattillo,et al.  Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line. , 1977, Science.

[83]  J. Gordon,et al.  Creating and Maintaining the Gastrointestinal Ecosystem: What We Know and Need To Know from Gnotobiology , 1998, Microbiology and Molecular Biology Reviews.

[84]  J. Beaulieu,et al.  Integrins as mediators of epithelial cell‐matrix interactions in the human small intestinal mucosa , 2000, Microscopy research and technique.

[85]  S. Salminen,et al.  Specific probiotic strains and their combinations counteract adhesion of Enterobacter sakazakii to intestinal mucus. , 2008, FEMS microbiology letters.

[86]  T. Savidge,et al.  Modulation of Human Intestinal Epithelial Cell IL-8 Secretion by Human Milk Factors , 2003, Pediatric Research.

[87]  S. Salminen,et al.  Competitive exclusion of enteropathogens from human intestinal mucus by Bifidobacterium strains with acquired resistance to bile--a preliminary study. , 2007, International journal of food microbiology.

[88]  J. Beaulieu,et al.  Differential expression of the integrins α6Aβ4 and α6Bβ4 along the crypt–villus axis in the human small intestine , 2009, Histochemistry and Cell Biology.

[89]  M. Roselli,et al.  Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response induced by enterotoxigenic Escherichia coli K88. , 2006, The British journal of nutrition.

[90]  A. Henriques,et al.  Characterization of Bacillus Probiotics Available for Human Use , 2004, Applied and Environmental Microbiology.

[91]  J. Alper Glycobiology. Turning sweet on cancer. , 2003, Science.

[92]  D. Jewell,et al.  Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation. , 1992, Gut.

[93]  H. Glise,et al.  The role of the gut flora in health and disease, and its modification as therapy , 2002, Alimentary pharmacology & therapeutics.

[94]  R. Nurieva,et al.  Yin–Yang of costimulation: crucial controls of immune tolerance and function , 2009, Immunological reviews.

[95]  E. Levy,et al.  Localization, function and regulation of the two intestinal fatty acid-binding protein types , 2009, Histochemistry and Cell Biology.

[96]  D. Philpott,et al.  A new role for intestinal alkaline phosphatase in gut barrier maintenance. , 2008, Gastroenterology.